MCT4 as a potential therapeutic target to augment gemcitabine chemosensitivity in resected pancreatic cancer.
Cell Oncol (Dordr)
; 44(6): 1363-1371, 2021 Dec.
Article
in En
| MEDLINE
| ID: mdl-34791637
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Pancreatic Neoplasms
/
Monocarboxylic Acid Transporters
/
Deoxycytidine
/
Molecular Targeted Therapy
/
Muscle Proteins
Type of study:
Etiology_studies
/
Incidence_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Humans
Language:
En
Journal:
Cell Oncol (Dordr)
Year:
2021
Document type:
Article
Country of publication:
Netherlands